ADAR and hereditary disease: This study revealed the extensive differences in substrate selectivity between the two active human ADARs, i.e., ADAR1 and ADAR2, and provided novel insight when utilizing the two different enzymes for in vivo treatment of human genetic diseases using the RNA editing approach.